OOIR: Observatory of International Research

Papers

(The H4-Index of Cytokine & Growth Factor Reviews is 36. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-10-01 to 2024-10-01.)

Article	Citations
SARS-CoV-2 Mutations and their Viral Variants	120
The NLRP3 inflammasome and COVID-19: Activation, pathogenesis and therapeutic strategies	103
The cytokine storm in COVID-19: Further advances in our understanding the role of specific chemokines involved	92
Crosstalk between glucose metabolism, lactate production and immune response modulation	90
Hallmarks of aging and immunosenescence: Connecting the dots	86
SARS-CoV-2 mediated neuroinflammation and the impact of COVID-19 in neurological disorders	84
Applications of the regenerative capacity of platelets in modern medicine	74
Mechanisms of NLRP3 priming in inflammaging and age related diseases	73
Correlation between PD-1/PD-L1 expression and polarization in tumor-associated macrophages: A key player in tumor immunotherapy	64
Is Toll-like receptor 4 involved in the severity of COVID-19 pathology in patients with cardiometabolic comorbidities?	59
Semaphorins in health and disease	54
Crosstalk between ferroptosis and the epithelial-mesenchymal transition: Implications for inflammation and cancer therapy	53
Pathophysiological role of growth differentiation factor 15 (GDF15) in obesity, cancer, and cachexia	53
Receptor binding competition: A paradigm for regulating TGF-β family action	50
SARS-CoV-2 infection and oxidative stress: Pathophysiological insight into thrombosis and therapeutic opportunities	50
The involvement of TH17 cells in the pathogenesis of IBD	48
ALCAM/CD166: A pleiotropic mediator of cell adhesion, stemness and cancer progression	48
FGF/FGFR signaling: From lung development to respiratory diseases	48
S100A8/A9 in COVID-19 pathogenesis: Impact on clinical outcomes	48
Scarless wound healing: Current insights from the perspectives of TGF-β, KGF-1, and KGF-2	47
Growth differentiation factor-15 and its role in diabetes and cardiovascular disease	47
Chemokine networks modulating natural killer cell trafficking to solid tumors	46
The evolving epidemiology of monkeypox virus	45
Recent advances in the treatment of IBD: Targets, mechanisms and related therapies	45
SARS-CoV-2: Targeted managements and vaccine development	44

Secretory Leukocyte Protease Inhibitor (SLPI) in mucosal tissues: Protects against inflammation, but promotes cancer	43
The RNA binding protein SRSF1 is a master switch of gene expression and regulation in the immune system	42
Cytokines in oncolytic virotherapy	41
Biological functions of NLRP3 inflammasome: A therapeutic target in inflammatory bowel disease	40
Engineering and combining oncolytic measles virus for cancer therapy	40
Antiphospholipid antibodies and risk of post-COVID-19 vaccination thrombophilia: The straw that breaks the camel's back?	40
Granulocyte macrophage colony-stimulating factor has come of age: From a vaccine adjuvant to antiviral immunotherapy	39
Biological functions and therapeutic opportunities of soluble cytokine receptors	39
The determinant role of IL-6 in the establishment of inflammation leading to spontaneous preterm birth	38
IL-36 in chronic inflammation and cancer	38
An evaluation of the effects of probiotics on tumoral necrosis factor (TNF-α) signaling and gene expression	38
Revisiting IRF1-mediated antiviral innate immunity	36
The immunosuppressive and pro-tumor functions of CCL18 at the tumor microenvironment	36